{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:52:53Z","timestamp":1784638373223,"version":"3.55.0"},"reference-count":23,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,3,29]]},"DOI":"10.18632\/oncotarget.7393","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T14:40:25Z","timestamp":1455547225000},"page":"15738-15746","source":"Crossref","is-referenced-by-count":15,"title":["Ubiquitin ligase UBE3C promotes melanoma progression by increasing epithelial-mesenchymal transition in melanoma cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Li","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Mei","family":"Yi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shanghai Skin Disease Hospital, Shanghai, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Juan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lou","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Lu","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Na","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Qing","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Feng","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shanghai Skin Disease Hospital, Shanghai, P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,2,15]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Jemal","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bjd.12492","article-title":"Emerging trends in the epidemiology of melanoma","volume":"170","author":"Stratigos","year":"2014","journal-title":"Br J Dermatol"},{"key":"3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/bjd.12698","article-title":"Major therapeutic developments and current challenges in advanced melanoma","volume":"170","author":"Flaherty","year":"2014","journal-title":"Br J Dermatol"},{"key":"4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1200\/JCO.2012.44.0958","article-title":"Role of ubiquitin ligases and the proteasome in oncogenesis: novel targets for anticancer therapies","volume":"31","author":"Eckhardt","year":"2013","journal-title":"J Clin Oncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.celrep.2015.04.049","article-title":"Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation","volume":"11","author":"Dummer","year":"2015","journal-title":"Cell reports"},{"key":"6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1755-148X.2009.00628.x","article-title":"Inhibition of Siah2 ubiquitin ligase by vitamin K3 (menadione) attenuates hypoxia and MAPK signaling and blocks melanoma tumorigenesis","volume":"22","author":"Ronai","year":"2009","journal-title":"Pigment cell & melanoma research"},{"key":"7","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1038\/sj.onc.1209688","article-title":"A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion","volume":"25","author":"Ohtsuki","year":"2006","journal-title":"Oncogene"},{"key":"8","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1002\/hep.27012","article-title":"Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing","volume":"59","author":"Zhou","year":"2014","journal-title":"Hepatology"},{"key":"9","doi-asserted-by":"crossref","first-page":"e0115622","DOI":"10.1371\/journal.pone.0115622","article-title":"UBE3C promotes growth and metastasis of renal cell carcinoma via activating Wnt\/beta-catenin pathway","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10","doi-asserted-by":"crossref","first-page":"11066","DOI":"10.1038\/srep11066","article-title":"Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7","volume":"5","author":"Sun","year":"2015","journal-title":"Scientific reports"},{"key":"11","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1158\/1055-9965.EPI-12-0327","article-title":"Time to get serious about skin cancer prevention","volume":"21","author":"Vogel","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.14348\/molcells.2015.2120","article-title":"Itch E3 ubiquitin ligase positively regulates TGF-beta signaling to EMT via Smad7 ubiquitination","volume":"38","author":"Woo","year":"2015","journal-title":"Molecules and cells"},{"key":"13","doi-asserted-by":"publisher","first-page":"862","DOI":"10.18632\/oncotarget.2696","article-title":"The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer","volume":"6","author":"Moller","year":"2015","journal-title":"Oncotarget"},{"key":"14","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1210\/me.2015-1125","article-title":"Liganded ERalpha Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation","volume":"29","author":"Ohta","year":"2015","journal-title":"Molecular endocrinology"},{"key":"15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.molcel.2015.01.042","article-title":"Assembly and specific recognition of k29- and k33-linked polyubiquitin","volume":"58","author":"Komander","year":"2015","journal-title":"Mol Cell"},{"key":"16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.molcel.2015.01.041","article-title":"K29-selective ubiquitin binding domain reveals structural basis of specificity and heterotypic nature of k29 polyubiquitin","volume":"58","author":"Kulathu","year":"2015","journal-title":"Mol Cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"re8","DOI":"10.1126\/scisignal.2005189","article-title":"Signaling mechanisms of the epithelial-mesenchymal transition","volume":"7","author":"Medici","year":"2014","journal-title":"Science signaling"},{"key":"18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Weinberg","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"19","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.tig.2012.05.005","article-title":"Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition","volume":"28","author":"Wu","year":"2012","journal-title":"Trends Genet"},{"key":"20","first-page":"43","article-title":"Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?","volume":"1855","author":"Yu","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"21","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1365-2133.2007.08246.x","article-title":"Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma","volume":"157","author":"Biagini","year":"2007","journal-title":"Br J Dermatol"},{"key":"22","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1038\/onc.2015.7","article-title":"PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing beta-catenin expression and nuclear translocation","volume":"34","author":"Xie","year":"2015","journal-title":"Oncogene"},{"key":"23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/hep.26398","article-title":"PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1alpha expression and protein stability","volume":"58","author":"Xie","year":"2013","journal-title":"Hepatology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T18:27:13Z","timestamp":1589221633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,15]]},"references-count":23,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,3,29]]}},"alternative-id":["7393","26894856"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7393","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,15]]}}}